Get the Stockscreener App
3.54
7.93%
0.26
180 Life Sciences Corp stock is traded at $3.54, with a volume of 3.31M.
It is up +7.93% in the last 24 hours and up +297.75% over the past month.
180 Life Sciences Corp was formed as a clinical-stage biotechnology company, focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation, and fibrosis by employing research, and, where appropriate, combination therapy. In addition, it has acquired certain source code and intellectual property relating to the back-end technology platform to operate an online blockchain casino, and moving forward, it plans to focus the majority of its operations on the creation of the online blockchain casino, while looking to monetize certain prior development-stage therapeutic product candidates for unmet medical needs. It has one reportable operating segment, iGaming.
See More
Previous Close:
$3.28
Open:
$2.96
24h Volume:
3.31M
Relative Volume:
1.54
Market Cap:
$21.38M
Revenue:
-
Net Income/Loss:
$-3.12M
P/E Ratio:
-0.7352
EPS:
-4.8149
Net Cash Flow:
$-2.69M
1W Performance:
+18.00%
1M Performance:
+297.75%
6M Performance:
+152.86%
1Y Performance:
+68.57%
1-Day Range:
$2.72
$3.57
1-Week Range:
$2.55
$4.75
52-Week Range:
$0.6578
$17.75
180 Life Sciences Corp Stock (ATNF) Company Profile
Name
180 Life Sciences Corp
Sector
Industry
Phone
650-507-0669
Address
3000 EL CAMINO REAL, PALO ALTO
Compare ATNF with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ATNF
180 Life Sciences Corp
|
3.54 | 19.81M | 0 | -3.12M | -2.69M | -4.8149 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
180 Life Sciences Corp Stock (ATNF) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-15-21 | Initiated | Maxim Group | Buy |
180 Life Sciences Corp Stock (ATNF) Latest News
How volatile is 180 Life Sciences Corp. Equity Warrant stock compared to the marketFree Stock Review Backed By Experts - jammulinksnews.com
What is 180 Life Sciences Corp. company’s growth strategyRetirement Planning Entry Points For Every Investor - jammulinksnews.com
Monster week for crypto treasury firms with $8B buying blitz - TradingView
Why is 180 Life Sciences Corp. Equity Warrant stock attracting strong analyst attentionAI Powered Signals For Consistent Profits - jammulinksnews.com
180 Life Sciences Secures $425 Million to Build ETH Treasury - Bitcoin.com News
What are analysts’ price targets for 180 Life Sciences Corp. in the next 12 monthsEntry Signal Growth Plan That Work - jammulinksnews.com
When is 180 Life Sciences Corp. stock expected to show significant growthValue Investing Outlook With Proven Results - jammulinksnews.com
Ethereum News Today: ETHZilla raises $425M to build Ethereum treasury firm - AInvest
180 life science - AInvest
How institutional ownership impacts 180 Life Sciences Corp. stockHigh Reward Investment Strategy for Beginners - Newser
Life Sciences Company 180 Pivots to Ethereum Strategy with $425M Funding Round - blockhead.co
What to do if you’re stuck in 180 Life Sciences Corp.Buy Candidate Summary Based on Fundamentals - Newser
Is 180 Life Sciences Corp. a growth stock or a value stockPost Market Recommendation For 2025 - jammulinksnews.com
180 Life Sciences Announces $425M Private Placement Deal - TipRanks
What candlestick patterns are forming on 180 Life Sciences Corp.Ten-Year Sector Performance and Summary Analysis - Newser
180 Life Sciences Corp. Equity Warrant stock retracement – recovery analysisFree Entry Plan for Oversold Reversal Stocks - Newser
Technical analysis overview for 180 Life Sciences Corp. Equity Warrant stockFree Top Gaining Picks With Entry Signals - Newser
Why 180 Life Sciences Corp. Equity Warrant stock attracts strong analyst attention - Newser
Is 180 Life Sciences Corp. Stock a Good Fit for Conservative InvestorsStock Portfolio Allocation Guidance for Volatile Markets - metal.it
New Product Launches: Will They Boost 180 Life Sciences Corp. Equity Warrant Stock in 2025Free Triple Digit Growth Focused Trade Plan - Newser
180 Life Sciences Eyes $425M Raise for ETH Treasury, as It Rebrands to ETHZilla - NFTgators
Ethereum News Today: ETHZilla Rebrands as $425M Ethereum Investment Drives 95% Cash Shift to DeFi - AInvest
Ethereum News Today: Nasdaq-listed 180 Life Sciences down 99.9% since 2020 IPO pivots to crypto with $425M ETH investment - AInvest
Down 99%, Biotech Firm 180 Life Sciences Pivots To Crypto With ETH Bet - Cointelegraph
180 Life Sciences Rebrands as ETHZilla, Unleashes $425M Ethereum Treasury Raise - Cryptonews
Another Ethereum Treasury Play: 180 Life Sciences Raises $425 Million To Buy ETH - Benzinga
180 Life Sciences Corp. (ATNF) Stock: Surge Amid Bold Pivot to $425M Ethereum Treasury and Rebrand to ETHZilla - CoinCentral
Ethereum News Today: 180 Life Sciences Raises $425M for Ethereum Reserve Rebrands as ETHZilla - AInvest
180 Life Sciences announce an upsized $425 million Private Placement to establish an Ether treasury reserve led by consortium of digital asset leaders to launch Ethzilla - MarketScreener
New Ether Treasury Firm 'ETHZilla' Emerges With $425M Funding and a DeFi Twist - Yahoo.co
180 Life Sciences to raise $425 million for Ethereum treasury strategy By Investing.com - Investing.com South Africa
180 Life Sciences to raise $425 million for Ethereum treasury strategy - Investing.com Australia
180 Life Sciences Secures $425M to Launch Revolutionary Ethereum Treasury Strategy with Crypto Elite Backing - Stock Titan
Price Consolidation Hints at Upcoming Move in 180 Life Sciences Corp.Quick Gain Stock Watch With Indicators Reviewed - metal.it
Traders Watching For Reversal Pattern in 180 Life Sciences Corp.Chart Breakout Buy Signal Detection Confirmed - metal.it
Is 180 Life Sciences Corp. Stock a Smart Buy in 2025 Investment Analysis InsideFree Secure Return Focused Investment Plan - Newser
180 Life Sciences Announce an Upsized $425 Million Private Placement to Establish an Ether Treasury Reserve Led by Consortium of Digital Asset Leaders to Launch ETHZilla - Ariva
Biotech Firm 180 Life Sciences Rebrands to ETHZilla after $425M ETH Treasury Deal - Bitget
What makes 180 Life Sciences Corp. stock price move sharplyFree Short Term Buy List With Stop Protection - Newser
Trapped Investors in 180 Life Sciences Corp. Await Breakout SignalWeekly Stock Opportunity Radar Scanner Activated - metal.it
How volatile is 180 Life Sciences Corp. stock compared to the marketRetirement Planning Alerts That Work - jammulinksnews.com
180 Life Sciences Corp.Warrant (Nasdaq:ATNFW) Stock Quote - FinancialContent
When is 180 Life Sciences Corp. Equity Warrant stock expected to show significant growthMarket-crushing profits - jammulinksnews.com
What are analysts’ price targets for 180 Life Sciences Corp. Equity Warrant in the next 12 monthsInvest confidently with real-time updates - jammulinksnews.com
How does 180 Life Sciences Corp. generate profit in a changing economyUnlock daily market insights for better trades - jammulinksnews.com
Real time alert setup for 180 Life Sciences Corp. Equity Warrant performanceWeekly Outlook for Short Term Investors - Newser
Why Celcuity Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket - Benzinga
180 Life Sciences Corp. (ATNF) Plunges 15% on Share Increase, FDA Review - AInvest
Is it the right time to buy 180 Life Sciences Corp. Equity Warrant stockFinancial News Alerts With Low Risk - jammulinksnews.com
Why is 180 Life Sciences Corp. stock attracting strong analyst attentionDiscover breakthrough investment opportunities - jammulinksnews.com
What is 180 Life Sciences Corp. Equity Warrant company’s growth strategyUnrivaled growth potential - jammulinksnews.com
180 Life Sciences Corp Stock (ATNF) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):